Aviva’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-796
| Closed | -$217K | – | 890 |
|
|
2024
Q2 | $217K | Sell |
796
-4
| -0.5% | -$1.09K | ﹤0.01% | 895 |
|
|
2024
Q1 | $277K | Sell |
800
-1,221
| -60% | -$422K | ﹤0.01% | 929 |
|
|
2023
Q4 | $653K | Sell |
2,021
-10,365
| -84% | -$3.35M | ﹤0.01% | 786 |
|
|
2023
Q3 | $4.44M | Buy |
12,386
+11,558
| +1,396% | +$4.14M | 0.02% | 525 |
|
|
2023
Q2 | $314K | Hold |
828
| – | – | ﹤0.01% | 924 |
|
|
2023
Q1 | $397K | Sell |
828
-2,082
| -72% | -$997K | ﹤0.01% | 948 |
|
|
2022
Q4 | $1.22M | Sell |
2,910
-51
| -2% | -$21.4K | 0.01% | 764 |
|
|
2022
Q3 | $1.24M | Sell |
2,961
-48
| -2% | -$20K | 0.01% | 892 |
|
|
2022
Q2 | $1.49M | Sell |
3,009
-2,222
| -42% | -$1.1M | 0.01% | 920 |
|
|
2022
Q1 | $2.95M | Sell |
5,231
-4,504
| -46% | -$2.54M | 0.01% | 703 |
|
|
2021
Q4 | $7.36M | Buy |
9,735
+1,138
| +13% | +$860K | 0.03% | 482 |
|
|
2021
Q3 | $6.41M | Buy |
8,597
+1,767
| +26% | +$1.32M | 0.03% | 508 |
|
|
2021
Q2 | $4.4M | Sell |
6,830
-2,341
| -26% | -$1.51M | 0.02% | 630 |
|
|
2021
Q1 | $5.24M | Sell |
9,171
-252
| -3% | -$144K | 0.03% | 528 |
|
|
2020
Q4 | $5.49M | Sell |
9,423
-1,471
| -14% | -$857K | 0.03% | 477 |
|
|
2020
Q3 | $5.62M | Buy |
10,894
+5,612
| +106% | +$2.89M | 0.03% | 421 |
|
|
2020
Q2 | $2.39M | Sell |
5,282
-5,534
| -51% | -$2.5M | 0.01% | 592 |
|
|
2020
Q1 | $3.79M | Buy |
10,816
+5,603
| +107% | +$1.96M | 0.03% | 494 |
|
|
2019
Q4 | $1.93M | Buy |
+5,213
| New | +$1.93M | 0.01% | 752 |
|